ASX Release 30 October 2026 Quarterly Activities Report and Appendix 4C for the Quarter Ended 30 September 2026 Epsilon Healthcare Delivers 34% YOY Increase in September Quarter Receipts Highlights: ? Quarterly receipts were $3.9m for the September 2026 quarter ? YTD revenue $11.5m, tracking at...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Epsilon Healthcare Limited on 6ix
Story so far
Earlier from Epsilon Healthcare
- Preliminary Final Report
- Epsilon Pharma signs manufacturing agreement with Puro NZ
- Reinstatement to Quotation
- Pre-reinstatement Disclosure
- Strengthening working capital position
Follow Epsilon Healthcare into a list and get an email when it puts out news.
Follow Epsilon Healthcare